# A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron.

> **NCT01284868** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 12 (actual)

## Conditions studied

- Healthy Volunteers
- Pharmacodynamics of Mirabegron

## Interventions

- **DRUG:** mirabegron
- **DRUG:** Bisoprolol
- **DRUG:** propranolol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01284868
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01284868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01284868, "A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01284868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*